APA (7th ed.) Citation

Kipps, T. J., Fraser, G., Coutre, S. E., Brown, J. R., Barrientos, J. C., Barr, P. M., . . . Hallek, M. (2019). Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia. Clinical lymphoma, myeloma and leukemia, 19(11), 715-722.e6. https://doi.org/10.1016/j.clml.2019.07.004

Chicago Style (17th ed.) Citation

Kipps, Thomas J., et al. "Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia." Clinical Lymphoma, Myeloma and Leukemia 19, no. 11 (2019): 715-722.e6. https://doi.org/10.1016/j.clml.2019.07.004.

MLA (9th ed.) Citation

Kipps, Thomas J., et al. "Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia." Clinical Lymphoma, Myeloma and Leukemia, vol. 19, no. 11, 2019, pp. 715-722.e6, https://doi.org/10.1016/j.clml.2019.07.004.